Haemonetics

Yahoo Finance • 3 days ago

Solventum is the top performing healthcare supplies stock YTD

[Monitors used during Cardiac Surgery] Arctic-Images/DigitalVision via Getty Images The S&P healthcare index (XLV [https://seekingalpha.com/symbol/XLV]) saw moderate gains in 2025, reaching a YTD increase of 12.2% by mid-December, though... Full story

Yahoo Finance • 9 days ago

Should Competitive Pressure In Vascular Closure Devices Prompt a Reassessment by Haemonetics (HAE) Investors?

Earlier this week, Needham downgraded Haemonetics from “Buy” to “Hold,” pointing to intensifying competition in vascular closure devices from Abbott and Cordis and warning that this could weigh on the company’s Interventional Technologies... Full story

Yahoo Finance • 10 days ago

Riverwater Partners Small Cap Strategy Sold Its Stake in Haemonetics Corporation (HAE) in Q3

Riverwater Partners, an investment management company, released its “Small Cap Strategy” Q3 2025 investor letter. A copy of the letter can be downloaded here. The Small Cap Core Strategy reported solid results for the quarter but did not k... Full story

Yahoo Finance • 30 days ago

Haemonetics Reaches Analyst Target Price

In recent trading, shares of Haemonetics Corp. (Symbol: HAE) have crossed above the average analyst 12-month target price of $80.40, changing hands for $80.63/share. When a stock reaches the target an analyst has set, the analyst logicall... Full story

Yahoo Finance • last month

A Look at Haemonetics’s (HAE) Valuation Following a 51% 30-Day Share Price Surge

Haemonetics (HAE) has seen a lift in its stock price over the past month, gaining more than 51%. This move stands out when compared to the company’s broader track record and recent financial performance. See our latest analysis for Haemon... Full story

Yahoo Finance • 2 months ago

SG Capital Dumps Nearly 732,000 Haemonetics Shares Worth $59.1 Million

Key Points SG Capital sold 731,892 shares of Haemonetics. The investment firm currently holds 175,000 shares. The position now represents 0.8% of AUM, which places it outside the fund's top five holdings.These 10 stocks could mint the nex... Full story

Yahoo Finance • 2 months ago

Stocks making the biggest moves midday: Brighthouse Financial, Duolingo, Datadog, Snap & more

Check out the companies making the biggest moves midday: Brighthouse Financial — The insurance company soared 26% on after it announced it would be bought by Aquarian Capital for $70 per share in cash, or around $4.1 billion. The deal is e... Full story

Yahoo Finance • 2 months ago

Haemonetics Non-GAAP EPS of $1.27 beats by $0.16, revenue of $327M beats by $15.51M

* Haemonetics press release [https://seekingalpha.com/pr/20296106-haemonetics-corporation-announces-second-quarter-fiscal-2026-financial-results-available-on] (HAE [https://seekingalpha.com/symbol/HAE]): Q2 Non-GAAP EPS of $1.27 beats by... Full story

Yahoo Finance • 2 months ago

Haemonetics Q2 2026 Earnings Preview

* Haemonetics (HAE [https://seekingalpha.com/symbol/HAE]) is scheduled to announce Q2 earnings results on Thursday, November 6th, before market open. The consensus EPS Estimate is $1.11 [https://seekingalpha.com/symbol/HAE/earnings/estim... Full story

Yahoo Finance • 2 months ago

Should You Hold Haemonetics Corporation (HAE)?

Aristotle Capital Boston, LLC, an investment advisor, released its “Small/Mid Cap Equity Strategy” third-quarter 2025 investor letter. A copy of the letter can be downloaded here. U.S. small/mid-cap equities reported solid results in the t... Full story

Yahoo Finance • 3 months ago

Dentsply Sirona, Acadia Healthcare, and Haemonetics Stocks Trade Down, What You Need To Know

What Happened? A number of stocks fell in the afternoon session after worries over worsening trade relations with China were triggered by critical comments from President Donald Trump. The president's tone and the suggestion of canceling... Full story

Yahoo Finance • 3 months ago

TomTom signs multi-year agreement to deliver traffic services to Hyundai AutoEver’s navigation for European vehicle lineup

Hyundai AutoEver (HAE) and TomTom expand their partnership to equip vehicles across Europe with TomTom technology. TomTom Real-Time Traffic and Speed Camera Service to enhance HMG drivers’ in-dash navigation experience. AMSTERDAM, Oct. 0... Full story

Yahoo Finance • 3 months ago

Haemonetics Corporation (HAE) Launches PerQseal Elite, Advancing Minimally Invasive Vascular Care

In this article, we will be taking a look at the 13 Most Oversold Healthcare Stocks So Far in 2025. Haemonetics Corporation is one of them. Haemonetics Corporation (NYSE:HAE), a global leader in blood and plasma management technologies, c... Full story

Yahoo Finance • 3 months ago

RSI Alert: Haemonetics (HAE) Now Oversold

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the R... Full story

Yahoo Finance • 4 months ago

Mizuho lowers Haemonetics stock price target to $70 on VASCADE MVP slowdown

Investing.com - Mizuho lowered its price target on Haemonetics (NYSE:HAE) to $70.00 from $90.00 on Thursday, while maintaining an Outperform rating on the stock. According to InvestingPro analysis, the company appears undervalued at curren... Full story

Yahoo Finance • 4 months ago

Chuck Royce's Strategic Moves: A Closer Look at Kennedy-Wilson Holdings Inc.

Exploring the Latest 13F Filing and Investment Strategies Chuck Royce (Trades, Portfolio) recently submitted the 13F filing for the second quarter of 2025, providing insights into his investment moves during this period. Charles M. Royce... Full story

Yahoo Finance • 5 months ago

Notable Two Hundred Day Moving Average Cross - HAE

In trading on Friday, shares of Haemonetics Corp. (Symbol: HAE) crossed below their 200 day moving average of $75.69, changing hands as low as $75.59 per share. Haemonetics Corp. shares are currently trading off about 1.6% on the day. Th... Full story

Yahoo Finance • 5 months ago

GVS H1 2025 presentation: EBITDA margins reach post-pandemic high despite mixed sales

Introduction & Market Context Italian filtration specialist GVS SpA presented its H1 2025 results on August 7, 2025, highlighting improved profitability metrics despite modest overall sales growth. The company’s stock traded at €4.98 on p... Full story

Yahoo Finance • 5 months ago

Haemonetics earnings beat by $0.09, revenue topped estimates

Investing.com - Haemonetics (NYSE: HAE) reported first quarter EPS of $1.10, $0.09 better than the analyst estimate of $1.01. Revenue for the quarter came in at $321.39M versus the consensus estimate of $302.62M. Haemonetics’s stock price... Full story

Yahoo Finance • 5 months ago

How The Pieces Add Up: SPMD Targets $63

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied... Full story